Detalhe da pesquisa
1.
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 25(1): 76-85, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048802
2.
Reversal of the immunosuppressive tumor microenvironment via platinum-based neoadjuvant chemotherapy in cervical cancer.
Cancer Pathog Ther
; 2(1): 38-49, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328710
3.
Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Int Immunopharmacol
; 122: 110601, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418988
4.
Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.
BMJ Open
; 13(5): e067767, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37253491
5.
Identification of key genes and immune cell infiltration in recurrent implantation failure: A study based on integrated analysis of multiple microarray studies.
Am J Reprod Immunol
; 88(4): e13607, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929523
6.
Melatonin Protects Rabbit Somatic Cell Nuclear Transfer (SCNT) Embryos from Electrofusion Damage.
Sci Rep
; 10(1): 2186, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32042116